Month: July 2023

Neuma Develops Disinfecting Cap That Mechanically Cannot Be Used More Than Once

PALO ALTO, Calif., July 11, 2023 (Newswire.com)
–
Neuma Innovations^TM, creator of the original Neuma Clamp^TM that deters and detects central line abuse by IVDU (intravenous drug using) patients, today announced the development of a new disinfecting cap that prevents reuse and is tamper-evident.

“We’ve been working closely with infusion professionals since 2015 to design solutions to problems associated with central line blood infections. We learned that about 28% of caregivers use the same disinfecting cap more than once, which obviously compromises the caps’ effectiveness. Our team set out to design a simple device that, because it can’t be reattached after the first use, dramatically improves compliance,” said Hal Rucker, President of Neuma Innovations. “The added benefit is that our cap also protects lines from patients who use their lines to self-inject illicit drugs.”

NO CHANGES TO WORKFLOWS

The Neuma Cap^TM disinfects, approaches 100% compliance, minimizes the harmful consequences of abuse by IVDU patients, facilitates the discharge to SNF and OPAT care, and fits seamlessly into existing workflows.

“The Neuma Cap genuinely ensures the enforcement of single-use protocols while its price point remains on par with comparable alternatives,” said Amy Duncan, Director of Business Development. “The ingenuity of Neuma’s product lies in its indistinguishable resemblance to conventional disinfecting caps without requiring any changes in workflow. From the perspective of clinicians, the Neuma Cap is a frictionless industry disrupter for optimal patient care.”

About Neuma Innovations

Neuma Innovations develops simple medical products to solve complex medical problems.

Neuma Caps and Neuma Clamps are patent-protected. Neuma, Neuma Innovations, Neuma Clamp, Neuma Central Line Protection Clamp, Neuma Cap, and Neuma Disinfecting Cap are trademarks of Neuma Innovations, LLC. All Rights Reserved. 

Copyright © 2023 Neuma Innovations LLC

Contact Information:

Hal Rucker

President

[email protected]

(650) 759-1203

Original Source:

Neuma Innovations’ Single-Use IV Disinfecting Cap Improves CLABSI Prevention and Deters Central Line Abuse by IVDU Patients

Enhanced Revenue Integrity offering strengthens audits, denials management, clinical documentation improvement solutions, and coder education to improve healthcare systems’ financial wellness.

CARY, N.C., July 11, 2023 (Newswire.com)
–
AQuity Solutions, an industry-leading, tech-enabled Clinical Documentation Capture, Medical Coding, and Mid-Revenue Cycle solution supplier for healthcare provider organizations, announced the launch of its Revenue Integrity portfolio. The solutions include Claim Denial & Appeals Management, Coding Audits & Record Analysis, Claim & Edit Remediation, Clinical Documentation Improvement, and Medical Coding Education & Training services.

The highly customizable set of offerings drive revenue cycle quality and productivity, allowing hospitals, clinics, and physician practices to meet and exceed their quality benchmarks through strengthened documentation capture details, improved coding accuracy, and payer-specific claim preparations to solidify accurate revenue while ensuring compliance. AQuity’s unique consultative approach helps manage risks and improve quality.

“Our Revenue Integrity solutions positively impact our client’s financial success through our team of experienced consultants in over 30 specialties, including Cardiovascular Interventional Radiology (CVIR) and other complex sub-specialties,” noted Susan Gatehouse, AQuity’s VP of Revenue Integrity and RHIT, CCS, and ICD-10 CM/PCS AHIMA Certified Trainer. “AQuity drives revenue success by applying detailed coding, charging, billing assessments, claim auditing, denial management, and multifaceted education strategies.” 

“With increased financial pressures and growing regulatory scrutiny for all provider organizations, AQuity’s Revenue Integrity solutions ensure compliance and financial performance,” added Kashyap Joshi, AQuity’s CEO. “Our commitment to expand our Revenue Integrity offerings is in direct response to market needs and our commitment to help AQuity clients overcome their most challenging issues related to the revenue cycle.” 

About AQuity

Headquartered in Cary, NC, AQuity provides solutions for 21 of the Top 25 and over half of the Top 250 Health Systems in the United States. AQuity employs over 7,500 virtual scribe and medical transcription document capture specialists, medical coders, and revenue integrity specialists in multiple specialties across the United States, India, Australia, Canada, and the U.K. With over 40 years of experience in solutions for healthcare, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines. AQuity is privately held. https://aquitysolutions.com. 

Contact Information:

Dale Kivi

Senior Director of Communications

[email protected]

804.339.9017

Original Source:

AQuity Broadens Its Portfolio With Launch of Revenue Integrity Solutions

The merger will combine URA’s exclusive technology and expertise with Diamond Institute’s best fertility specialists to create one of the strongest networks of fertility clinics in northern New Jersey and New York.

HASBROUCK HEIGHTS, N.J., July 11, 2023 (Newswire.com)
–
University Reproductive Associates (URA) and Diamond Institute today announced a merger that will create one of the most technologically advanced networks of fertility clinics in northern New Jersey and New York, as well as the most personalized. Both URA and Diamond Institute have built their successes on excellence in care, from initial evaluation to guidance on financial assistance. That care will now be available at six offices in six counties. New Jersey offices: Hasbrouck Heights in Bergen County, Wayne in Passaic County, Millburn in Essex County, Denville in Morris County and Hoboken in Hudson County. New York office: Goshen in Orange County.

According to Peter McGovern, M.D., a founding physician at URA, the merger will result in a new level of fertility care and solutions as more treatment options will be available, delivered with the one-on-one, personal care for which both organizations are known among their patients. URA is already the first and only fertility clinic network in New Jersey to offer the LifeAire in-duct air purification system, leading to a 15%-20% higher chance of successful implantation and pregnancy. URA is also the only network of fertility clinics in New Jersey to offer robotic surgery using the da Vinci^® Surgical System. 

From Diamond Institute, the merger will bring to URA two leading fertility specialists in New Jersey, Dr. Matan Yemini and Dr. Ndidiamaka Onwubalili. Dr. Yemeni brings 30 years of experience focusing interest, practice and research on the spectrum of issues associated with reproductive endocrinology and infertility treatment. Dr. Yemeni is bilingual, also speaking Hebrew. Dr. Onwubalili, aka “Dr. O,” is board-certified in Obstetrics and Gynecology and Reproductive Endocrinology. She is a Fellow of the American Congress of Obstetricians, and her clinical and research focus includes polycystic ovarian syndrome, fertility preservation, uterine fibroids, and minimally invasive surgery.

“There’s no doubt that URA provides families-to-be with higher chances than most fertility clinics through technology. Combined with the warm, personal care that’s already our standard with each and every couple, I think the merger will create something even better than the sum of its parts,” Dr. Onwubalili said.

Contact Information:

Leonard Schwartz

Practice Manager

[email protected]

201-288-6330

Original Source:

University Reproductive Associates Merges With Diamond Institute to Create a Network of Fertility Clinics in Both Northern New Jersey and New York